ceralifimod: Clinical Trials

2 trials of ceralifimod, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1

Follow ceralifimod: new trials by email Literature Review of ceralifimod trials Research Report on ceralifimod

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 2 Extension Trial in Patients With Relapsing-Remitting Multiple Sclerosis (RRMS)
ONO-4641 - Multiple Sclerosis
Phase 2TerminatedEMD Serono3402010-10-012016-07-12
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis
ONO-4641, ONO-4641 placebo - Multiple Sclerosis
Phase 2CompletedOno Pharma USA Inc4072010-03-012013-12-25

Conditions studied

Multiple Sclerosis (2)

Sponsors

EMD Serono (1)  ·  Ono Pharma USA Inc (1)

Countries

Belgium (2)  ·  Canada (2)  ·  Czechia (2)  ·  Germany (2)  ·  Greece (2)  ·  Japan (2)  ·  Poland (2)  ·  Russia (2)  ·  Spain (2)  ·  Ukraine (2)  ·  United States (2)